New Delhi: The GST Council is likely to clarify on the definition of multi utility vehicles (MUVs) and crossover utility vehicles (XUVs) for levy of 22 per cent compensation cess over and above the 28 per cent GST rate, sources said.
The Council is expected to clarify on the issue in its next meeting on July 11, they said.
The Fitment Committee, comprising tax officials from the Centre and states, has recommended to the GST Council to define MUVs and XUVs on par with the sports utility vehicles (SUVs) for the purpose of Goods and Services Tax (GST).
The committee has recommended that all utility vehicles, by whatever name called, would attract 22 per cent cess provided they meet three parameters — length greater than 4-metre, engine capacity greater than 1500 cc and ground clearance more than 170 mm.
The GST Council, chaired by the Union finance minister and comprising her state counterparts, had in December last year clarified on the definition of SUVs. At that time, some states had asked for a similar clarification for MUVs.
Separately, the Fitment Committee also recommended that Integrated GST (IGST) be exempted on cancer medicine, Dinutuximab (Quarziba), imported by individuals for personal use. Currently, the medicine import attracts 12 per cent IGST.
Dear Reader,
Every day, our team at EastMojo travels through rain, rough roads, and remote hills to bring you stories that matter – stories from your town, your people, your Northeast.
We do this because we believe in truthful, independent journalism. No big corporate backing, no government pressure – just honest reporting by local journalists who live and breathe the same air you do.
But to keep doing this work, we need you. Your small contribution helps us pay our reporters fairly, reach places others ignore, and keep asking the tough questions.
If you believe the Northeast deserves its own fearless voice, stand with us.
Support independent journalism. Be a Member.
Thank you,
Karma Paljor
Editor-in-Chief, eastmojo.com
It also recommended IGST exemption on medicines and food for special medical purposes used in the treatment of rare diseases which are imported for personal use subject to existing conditions and when imported by Centres of Excellence or any person or institution on recommendation of any of the listed Centre of Excellence.
Currently, such imports attract 5 per cent or 12 per cent IGST.
Also Read | GST collection rises 28% to Rs 1.43 lakh crore